Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer
End-stage renal disease (ESRD) coexisted with cirrhosis, ascites, and primary liver cancer represents an extraordinarily rare clinical condition that typically occurs in very late-stage decompensated cirrhosis and is associated with an extremely poor prognosis. We present a case of a 68-year-old mal...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Renal Failure |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2347461 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832591131303477248 |
|---|---|
| author | Lulu Sun Chunmei Liang Yuqin Wang Hui Li Lijun Yao Huajun Jiang |
| author_facet | Lulu Sun Chunmei Liang Yuqin Wang Hui Li Lijun Yao Huajun Jiang |
| author_sort | Lulu Sun |
| collection | DOAJ |
| description | End-stage renal disease (ESRD) coexisted with cirrhosis, ascites, and primary liver cancer represents an extraordinarily rare clinical condition that typically occurs in very late-stage decompensated cirrhosis and is associated with an extremely poor prognosis. We present a case of a 68-year-old male patient with ESRD who experienced various decompensated complications of liver cirrhosis, particularly massive ascites and hepatic space-occupying lesions. Peritoneal dialysis (PD) catheter insertion and continuous ambulatory peritoneal dialysis (CAPD) treatment were successfully performed. During meticulous follow-up, the patient survived for one year but ultimately succumbed to complications related to liver cancer. PD can serve as an efficacious therapeutic approach for such late-stage patients afflicted together with severe cirrhosis, massive ascites and primary liver cancer. |
| format | Article |
| id | doaj-art-d9fa8591acd940dbae8fdd95c758eca9 |
| institution | Kabale University |
| issn | 0886-022X 1525-6049 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Renal Failure |
| spelling | doaj-art-d9fa8591acd940dbae8fdd95c758eca92025-01-23T04:17:47ZengTaylor & Francis GroupRenal Failure0886-022X1525-60492024-12-0146110.1080/0886022X.2024.2347461Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancerLulu Sun0Chunmei Liang1Yuqin Wang2Hui Li3Lijun Yao4Huajun Jiang5Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaEnd-stage renal disease (ESRD) coexisted with cirrhosis, ascites, and primary liver cancer represents an extraordinarily rare clinical condition that typically occurs in very late-stage decompensated cirrhosis and is associated with an extremely poor prognosis. We present a case of a 68-year-old male patient with ESRD who experienced various decompensated complications of liver cirrhosis, particularly massive ascites and hepatic space-occupying lesions. Peritoneal dialysis (PD) catheter insertion and continuous ambulatory peritoneal dialysis (CAPD) treatment were successfully performed. During meticulous follow-up, the patient survived for one year but ultimately succumbed to complications related to liver cancer. PD can serve as an efficacious therapeutic approach for such late-stage patients afflicted together with severe cirrhosis, massive ascites and primary liver cancer.https://www.tandfonline.com/doi/10.1080/0886022X.2024.2347461Liver cirrhosisascitesprimary liver cancerend-stage renal diseaseperitoneal dialysis |
| spellingShingle | Lulu Sun Chunmei Liang Yuqin Wang Hui Li Lijun Yao Huajun Jiang Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer Renal Failure Liver cirrhosis ascites primary liver cancer end-stage renal disease peritoneal dialysis |
| title | Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer |
| title_full | Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer |
| title_fullStr | Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer |
| title_full_unstemmed | Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer |
| title_short | Peritoneal dialysis in an end-stage renal disease patient with massive ascites and primary liver cancer |
| title_sort | peritoneal dialysis in an end stage renal disease patient with massive ascites and primary liver cancer |
| topic | Liver cirrhosis ascites primary liver cancer end-stage renal disease peritoneal dialysis |
| url | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2347461 |
| work_keys_str_mv | AT lulusun peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer AT chunmeiliang peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer AT yuqinwang peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer AT huili peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer AT lijunyao peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer AT huajunjiang peritonealdialysisinanendstagerenaldiseasepatientwithmassiveascitesandprimarylivercancer |